p53 mutant mice that display early ageing-associated phenotypes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53+/m) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53+/+) littermates. As p53+/m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, in mice, chronically active p53 both promotes cellular senescence and accelerates aging phenotypes [ 31 , 32 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [32]
In the citing paper
“Cells from these modified mice were more susceptible to both p53-mediated apoptosis (Tyner et al., 2002) and p53-mediated senescence (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Evidence for this idea comes from the phenotype of genetically modified mice in which p53 function was enhanced either by low-level expression of an artificially truncated p53 protein (Tyner et al., 2002; Maier et al., 2004) or modest overexpression of a naturally occurring short isoform (Maier et al., 2004).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Tyner et al., 2002
In the citing paper
“Delayed wound healing has been used as measure to characterize the aging phenotype of skin (170).”
From Wound repair and regeneration: Mechanisms, signaling, and translation (2014) · cites this paper as [170]
In the citing paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [18]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725
Self-citationThe p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349
Research works printed but not linked: 3
- Arking, R. Biology of Aging 2nd edn 153–250 (Sinauer, Sunderland, Massachusetts, 1998).
- Chuttani, A. & Gilchrest, B. A. in Handbook of Physiology, Section 11: Aging (ed. Masoro, E. J.) 309–324 (Oxford Univ. Press, New York, 1995).
- Muravchik, S. in Clinical Anesthesia 3rd edn (eds Barash, P. G., Cullen, B. F. & Stoelting, R. K.) 1125–1136 (Lippincott-Raven, Philadelphia, 1997).
Cited by
Items 801–900 of 1,000
Age-Related Dysfunctions: Evidence and Relationship with Some Risk Factors and Protective Drugs
Libertini, G., Corbi, G., Cellurale, M. T., & Ferrara, N. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919120034 · Cited by 27
The tumor suppression theory of aging
Wolf, A. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111583 · Cited by 30
Nicolás‐Espinosa, J., Yepes‐Molina, L., & Carvajal, M. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2021.2009522 · Cited by 26
“The expression of p53 is involved in ageing, and an overexpression of p53 in mice was shown to induce premature ageing phenotypes and the arrest of cellular proliferation (Tyner et al. 2002), being a good candidate marker in our experiments (Choudhary et al.”
ResultRenzo, L. D., Gratteri, S., Sarlo, F., Cabibbo, A., Colica, C., & LORENZO, A. D. (2014) · Disease Markers · doi:10.1155/2014/743634 · Cited by 25
“p53 is a tumour suppressor gene which responds to a variety of stress signals, including DNA damage, resulting in cell cycle arrest, apoptosis, or senescence, and several studies suggest that p53 protein activity plays a role in regulating muscle homeostasis, with an important role in the process of myoblasts differen…”
BackgroundOsteoblast progenitor fate and age-related bone loss.
Jilka, R. L. (2002) · PubMed · Cited by 24
Ageing–apoptosis relation in murine spleen
Itzhaki, O., Skutelsky, E., Kaptzan, T., Sinai, J., Michowitz, M., Huszar, M., & Leibovici, J. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00171-4 · Cited by 26
Selman, C., Gredilla, R., Phaneuf, S., Kendaiah, S., Barja, G., & Leeuwenburgh, C. (2003) · Biogerontology · doi:10.1023/a:1024149923693 · Cited by 24
“Interestingly, mice heterozygous for a p53 mutation had enhanced resistance to spontaneous tumors but an accelerated aging phenotype (Tyner et al. 2002).”
BackgroundA quantitative model of cellular senescence influence on cancer and longevity
Pompei, F., & Wilson, R. (2002) · Toxicology and Industrial Health · doi:10.1191/0748233702th164oa · Cited by 25
DNA repair and anti-cancer mechanisms in the long-lived bowhead whalePreprint
Firsanov, D., Zacher, M., Tian, X., Sformo, T. L., Zhao, Y., Tombline, G., Lu, J. Y., Zheng, Z., Perelli, L., Gurreri, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.07.539748 · Cited by 37
Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis
Fry, E. A., Taneja, P., Maglic, D., Zhu, S., Sui, G., & Inoue, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077870 · Cited by 24
Guilty as CHARGED: p53's expanding role in disease
Van Nostrand, J. L., & Attardi, L. D. (2014) · Cell Cycle · doi:10.4161/15384101.2014.987627 · Cited by 23
“strain, a C-terminal fragment of p53 is produced, provoking premature aging in p53m/C adults.(84) However, unlike the p5325,26,53,54/C embryos, there is no sign of increased basal p53 activity, and instead, stress signals are required to induce the p53 m protein to augment p53 stability and activity.”
BackgroundRecent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes
Berman, A. E., Leontieva, O. V., Natarajan, V., McCubrey, J. A., Demidenko, Z. N., & Nikiforov, M. A. (2012) · Oncotarget · doi:10.18632/oncotarget.889 · Cited by 29
“Not surprisingly, the effects of p53 on longevity may vary [33, 172-180].”
BackgroundUnprovoked Stabilization and Nuclear Accumulation of the Naked Mole-Rat p53 Protein
Deuker, M. M., Lewis, K. N., Ingaramo, M., Kimmel, J. C., Buffenstein, R., & Settleman, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64009-0 · Cited by 29
Hematopoietic Stem Cell Quiescence: Yet Another Role for p53
van Os, R. P., de Haan, G., & Dykstra, B. J. (2009) · Cell stem cell · doi:10.1016/j.stem.2008.12.007 · Cited by 24
“Constitutive expression of p53 has been associated with premature aging (Tyner et al., 2002).”
BackgroundSakai, H., Fujigaki, H., Mazur, S. J., & Appella, E. (2014) · Cell Cycle · doi:10.4161/cc.27920 · Cited by 26
Resveratrol Derivative-Rich Melinjo Seed Extract Attenuates Skin Atrophy inSod1-Deficient Mice
Watanabe, K., Shibuya, S., Ozawa, Y., Izuo, N., & Shimizu, T. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/391075 · Cited by 27
“In a genetically modified model, p53 activation induced accelerated aginglike phenotypes, including skin atrophy, in p53 mutant mice [34].”
BackgroundNeault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
Vascular senescence and ageing: a role for the MEOX proteins in promoting endothelial dysfunction
Northcott, J. M., Czubryt, M. P., & Wigle, J. T. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0149 · Cited by 25
Chmielewski, P. P. (2017) · Anthropological Review · doi:10.1515/anre-2017-0021 · Cited by 28
“Surprisingly, it is the other way round (Garcia-Cao et al. 2002; Tyner et al. 2002).”
BackgroundThe p53/Adipose-Tissue/Cancer Nexus
Zwezdaryk, K. J., Sullivan, D. E., & Saifudeen, Z. R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00457 · Cited by 26
Deletion of Ku80 causes early aging independent of chronic inflammation and Rag-1-induced DSBs
Holcomb, V. B., Vogel, H. S., & Hasty, P. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.08.006 · Cited by 27
“While the root cause may be defective chromosomal maintenance, the aging phenotype may actually be caused by cellular responses that are common to all these defects (Maier et al., 2004; Tyner et al., 2002).”
BackgroundCARF: An emerging regulator of p53 tumor suppressor and senescence pathway
Cheung, C., Hasan, M. K., Widodo, N., Kaul, S. C., & Wadhwa, R. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.05.002 · Cited by 26
“Mouse models with enforced increase in p53 activity have provided contrasting results due to differences in the transgenic p53 allele (Garcia-Cao et al., 2002; Lavigueur et al., 1989; Maier et al., 2004; Tyner et al., 2002).”
ResultPiltti, K. M., Kerosuo, L., Hakanen, J., Eriksson, M. D., Angers‐Loustau, A., Leppä, S., Salminen, M., Sariola, H. V., & Wartiovaara, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209492 · Cited by 27
Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice
Johnson, T. M., & Attardi, L. D. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401902 · Cited by 26
Developmental Acquisition of p53 Functions
Jaiswal, S. K., Raj, S., & Depamphilis, M. (2021) · Genes · doi:10.3390/genes12111675 · Cited by 25
“[26], regulating aging [27], and stimulating tissue regeneration [28].”
BackgroundTelomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
Quality control mechanisms in cellular and systemic DNA damage responses
Ermolaeva, M., Dakhovnik, A., & Schumacher, B. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.009 · Cited by 26
Maintenance of Genomic Stability in Mouse Embryonic Stem Cells: Relevance in Aging and Disease
Giachino, C., Orlando, L., & Turinetto, V. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022617 · Cited by 27
Constitutive and induced functions of the p53 gene
Zheltukhin, A. O., & Chumakov, P. M. (2010) · Biochemistry (Moscow) · doi:10.1134/s0006297910130110 · Cited by 33
Autophagy: A Promising Target for Age-related Osteoporosis
Wang, T., He, H., Liu, S., Jia, C., Fan, Z., Zhong, C., Yu, J., Liu, H., & He, C. (2018) · Current Drug Targets · doi:10.2174/1389450119666180626120852 · Cited by 24
The signaling pathways that mediate the anti-cancer effects of caloric restriction
Lu, Y., Tao, F., Zhou, M., & Tang, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.021 · Cited by 25
Its written all over your face: The molecular and physiological consequences of aging skin
Lowry, W. E. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111315 · Cited by 28
“particularly in proliferative tissues such as the epidermis(Klein et al., 2007; Lauri et al., 2014; Martincorena et al., 2015; Murai et al., 2018; Nassar et al., 2015; Singh et al., 2018; Tyner et al., 2002; Van Neste and Tobin, 2004; Wei, 1998).”
BackgroundHey, H. W. D., Lam, W. M. R., Chan, C. X., Zhuo, W., Crombie, E. M., Tan, T. C., Chen, W. C., Cool, S. M., & Tsai, S. (2021) · The Spine Journal · doi:10.1016/j.spinee.2021.09.003 · Cited by 21
“The occurrence of spinal kyphosis had been demonstrated in murine models with muscle dysfunction such as in the Duchenne muscular dystrophy (mdx) mouse model (13) and Bub1b +/GTTA progeroid mouse model (14), suggesting the possibility of muscle wasting as its cause (15, 16).”
BackgroundLiu, Z., Wu, B., Liu, X., Wu, X., Du, J., Xia, G., Cai, J.-N., Zhu, H., Sheng, X., Zhang, M., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.80461 · Cited by 22
“Multiple lines of evidence indicate that p53 is activated in response to cellular stress, to regulate apoptosis or cell cycle, thereby affecting the aging process [41-43].”
BackgroundGuardian of corpulence: a hypothesis on p53 signaling in the fat cell
Bazuine, M., Stenkula, K. G., Cam, M., Arroyo, M., & Cushman, S. W. (2009) · Clinical Lipidology · doi:10.2217/clp.09.2 · Cited by 23
Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities
Stahl, M. F., Kim, T. K., & Zeidan, A. M. (2016) · World Journal of Stem Cells · doi:10.4252/wjsc.v8.i10.316 · Cited by 20
Transcription factor p53 and skin aging
Gritsenko, D., Orlova, O. A., Linkova, N. S., & Khavinson, V. K. (2017) · Advances in Gerontology · doi:10.1134/s2079057017020072 · Cited by 23
“The dermis of aged (24 months) mice heterozygous for р53+/m, which carried the m allele, encoding a truncated p53 variant, was thinner than in wild-type animals [61].”
BackgroundEco‐evolutionary perspectives of the dynamic relationships linking senescence and cancer
Lemaître, J., Pavard, S., Giraudeau, M., Vincze, O., Jennings, G., Hamede, R., Újvári, B., & Thomas, F. (2019) · Functional Ecology · doi:10.1111/1365-2435.13394 · Cited by 22
A cancer‐causing gene is positively correlated with male aggression in Xiphophorus cortezi
Fernandez, A. A. (2009) · Journal of Evolutionary Biology · doi:10.1111/j.1420-9101.2009.01914.x · Cited by 21
“Thus, expression of TP53 represents a trade-off because it functions to decrease tumour susceptibility but also accelerates senescence (Tyner et al., 2002; Weinstein & Ciszek, 2002; Campisi, 2005; Krtolica, 2005).”
BackgroundRoles of p53 in Various Biological Aspects of Hematopoietic Stem Cells
Nii, T., Marumoto, T., & Tani, K. (2012) · BioMed Research International · doi:10.1155/2012/903435 · Cited by 23
“Mice expressing a truncated mutant of p53 lacking the first six exons (p53 mice) show hyperactive p53 activity, compared with that of wild-type mice, and exhibit an organismal aging phenotype such as reduced longevity, osteoporosis, generalized organ atrophy, and diminished stress tolerance [75].”
BackgroundCellular Respiration and Carcinogenesis
Sarangarajan, R., & Apte, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3 · Cited by 23
Vijg, J., & Suh, Y. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00163-x · Cited by 23
Levandowski, C. B., Jones, T., Gruca, M. A., Ramamoorthy, S., Dowell, R. D., & Taatjes, D. J. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3001364 · Cited by 19
“This was best exemplified in mouse studies in which truncated or naturally occurring Δ 40p53 isoforms were expressed together with WTp53 in roughly a 1:1 ratio [16,17].”
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program
Pant, V., Sun, C., & Lozano, G. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01123-2 · Cited by 26
“Constitutive activation of p53 has also been associated with aging phenotypes in mice (p53) and humans (MDM2 antiterminating mutation) [63, 64].”
BackgroundProtein–protein interactions for cancer therapy
Harris, C. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510948103 · Cited by 24
Deocaris, C. C., Takano, S., Priyandoko, D., Kaul, Z., Yaguchi, T., Kraft, D. C. E., Yamasaki, K., Kaul, S. C., & Wadhwa, R. (2008) · Biogerontology · doi:10.1007/s10522-008-9136-8 · Cited by 20
“Although detailed kinetics on how glycerol functions to induce proteasome activity is not addressed in the present study, we suspect some similarity in mechanisms to that of L-carnitine (Dahlmann et al. 1993; Thomas et al. 2005 ).”
ResultRole of Cellular Senescence in Lifestyle-Related Disease
Minamino, T. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0916 · Cited by 21
Volk, E. L., Schuster, K., Nemeth, K. M., Fan, L., & Harris, L. C. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000992 · Cited by 20
“For instance, the mutant p53 expressed in the p53+/m mice only showed increased p53 activity in a luciferase reporter assay when the mutant allele was ectopically expressed in Saos-2 cells (Tyner et al., 2002).”
BackgroundInfluentialTP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma
Rebbani, K., Marchio, A., Ezzikouri, S., Afifi, R., Kandil, M., Bahri, O., Triki, H., Feydi, A. E. E., Dejean, A., Benjelloun, S., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0340-2 · Cited by 20
“Moreover, as shown in mouse models, an excess of p53 activity is characterized by an aging-like syndrome [54].”
Lu, X., Wei, Y., & Liu, F. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.27 · Cited by 21
Self-citationReconstructing Signal Transduction Pathways: Challenges and Opportunities
Levine, A. J., Hu, W., Feng, Z., & Gil, G. A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1407.018 · Cited by 22
Golubovsky, M. D., Weisman, N. Y., Arbeev, K. G., Ukraintseva, S. V., & YASHIN, A. I. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.035 · Cited by 21
Schmid, G., Kramer, M. P., Maurer‐Granofszky, M., Wandl, S., & Węsierska‐Gądek, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21383 · Cited by 20
“The allele was the result of an aberrant gene-targeting event in embryonic stem cells [Tyner et al., 2002].”
BackgroundInfluentialChen, L., Liao, F., Wu, J., Wang, Z., Jiang, Z., Zhang, C., Luo, P., Ma, L., Gong, Q., Wang, Y., et al. (2021) · Aging Cell · doi:10.1111/acel.13370 · Cited by 19
“…systems, which are responsible for protein folding and degradation, both are observed to decrease with age (Kaushik & Cuervo, 2015), causing the accumulation of the misfolded or aggregated protein resulting in unbalanced proteostasis and accelerated ageing (Tawo et al., 2017; Vila et al., 2019).”
BackgroundProgress in research into systemic sclerosis
Kahaleh, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16864-5 · Cited by 20
Cao, H., Lei, S., Deng, H., & Wang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042755 · Cited by 19
de Grey, A. D. N. J., Campbell, F. C., Dokal, I. S., Fairbairn, L., Graham, G. J., Jahoda, C. A. B., & PORTERG, A. C. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.026 · Cited by 19
Emergence of new infectious diseases
Woolhouse, M. E. J., & Antia, R. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0016 · Cited by 23
Aging and cancer in transgenic and mutant mice
Anisimov, V. N. (2003) · Frontiers in bioscience · doi:10.2741/1122 · Cited by 19
Levkovitch-Verbin, H., Vander, S., Makarovsky, D., & Lavinsky, F. (2013) · PubMed Central · Cited by 22
Analysis of oncology research from 2001 to 2010: A scientometric perspective
Shao, H., YU, Q., BO, X., & Duan, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2239 · Cited by 19
Metabolic syndrome, hormones, and maintenance of T cells during aging
Hsu, H., & Mountz, J. D. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.05.002 · Cited by 18
The natural distribution of survival
Milne, E. M. G. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.07.021 · Cited by 20
Concepts in MDM2 Signaling: Allosteric Regulation and Feedback Loops
Ponnuswamy, A., Hupp, T. R., & Fåhræus, R. (2012) · Genes & Cancer · doi:10.1177/1947601912454140 · Cited by 22
Where Will We Draw the Line? Public Opinions of Human Gene Editing
Riggan, K. A., Sharp, R. R., & Allyse, M. A. (2019) · Qualitative Health Research · doi:10.1177/1049732319846867 · Cited by 22
Is cell death and replacement a factor in aging?
Warner, H. R. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.004 · Cited by 21
Thioredoxin‐binding protein‐2 (TBP‐2): Its potential roles in the aging process
Yoshida, T., Kondo, N., Oka, S., Ahsan, M. K., Hara, T., Masutani, H., Nakamura, H., & Ab, J. Y. (2006) · BioFactors · doi:10.1002/biof.5520270105 · Cited by 18
“spans if cellular proliferation was inhibited by DNA damage [7], DNA repair defects [4,31,35] enhanced apoptosis [29], or decreased telomere length [9,32].”
BackgroundGesing, A., Masternak, M. M., Wang, F., Lewiñski, A., Karbownik‐Lewińska, M., & Bartke, A. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010202 · Cited by 17
Developmental noise, ageing and cancer
Aranda‐Anzaldo, A., & Dent, M. A. R. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00089-7 · Cited by 20
“The tumour spectrum of p53 // /, p53 // / and p53 // / mice is remarkably the same showing a predominance of lymphomas and sarcomas, but rarely carcinomas ( Tyner et al., 2002 ).”
BackgroundInfluentialp53 and ageing: too much of a good thing?
Kirkwood, T. B. L. (2002) · BioEssays · doi:10.1002/bies.10111 · Cited by 20
Effect of Chronic Ethanol Ingestion and Gender on Heart Left Ventricular p53 Gene Expression
l, H. J. N., Eriksson, P., Eklund, K. K., Sarviharju, M., H�rk�nen, M., & ki, T. M. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000175043.67463.e5 · Cited by 17
Dorszewska, J., Oczkowska, A., Suwalska, M., Różycka, A., Florczak‐Wyspianska, J., Dezor, M., Lianeri, M., Jagodziński, P. P., Kowalczyk, M. J., Prendecki, M., et al. (2014) · Folia Neuropathologica · doi:10.5114/fn.2014.41742 · Cited by 20
“On the other hand, transgenic mice with truncated p53 exhibit enhanced resistance to spontaneous tu mours, but show reduced longevity [54].”
Global spatial patterns of infectious diseases and human evolution
Guégan, J., Prugnolle, F., & Thomas, F. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0002 · Cited by 17
Modulation of the p53 family network by RNA-binding proteins
Lucchesi, C. A., Zhang, J., & Chen, X. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.08.30 · Cited by 19
“The importance of strict p53 protein regulation is underscored by the fact that too much p53 leads to premature ageing (25) and cell death due to excessive apoptosis (26), whereas too little p53 has been shown to be a key aspect of tumorigenesis (27).”
BackgroundHow can aging be reversed? Exploring rejuvenation from a damage‐based perspective
Zhang, B., & Gladyshev, V. N. (2020) · Advanced Genetics · doi:10.1002/ggn2.10025 · Cited by 18
“overexpressed in mice, and the animals show a significantly shorter lifespan.(56) It should be noted, however, that similar cases of Tp53 overexpression in mouse models show an indistinguishable lifespan.”
BackgroundSnoN activates p53 directly to regulate aging and tumorigenesis
Pan, D., Zhu, Q., Conboy, M. J., Conboy, I. M., & Luo, K. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00857.x · Cited by 17
“p53 is activated by various stress signals to coordinate cell cycle arrest, apoptosis, senescence, and DNA repair processes (Vousden & Prives, 2009).”
BackgroundLifespan regulation under axenic dietary restriction: a close look at the usual suspects
Castelein, N., Cai, H., Rasulova, M., & Braeckman, B. P. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.07.015 · Cited by 19
Naru, E., Takanezawa, Y., Kobayashi, M., Misaki, Y., Kaji, K., & Arakane, K. (2008) · Human Cell · doi:10.1111/j.1749-0774.2008.00052.x · Cited by 18
Induction of p53 Expression and Function by Estrogen in Osteoblasts
Bovenkerk, S., Lanciloti, N., & Chandar, N. (2003) · Calcified Tissue International · doi:10.1007/s00223-002-1041-6 · Cited by 18
“In osteoblasts, while the role of E2 in increasing bonespecific markers of differentiation is well known [13], we believe that its association with a tumor suppressor gene is a novel finding and will be important to further define a role for this protein in bone differentiation, also given the fact that unregulated ov…”
BackgroundKoella, J. C., & Turner, P. E. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0017 · Cited by 18
Wafer, L. N., Streicher, W. W., McCallum, S. A., & Makhatadze, G. I. (2012) · Biochemistry · doi:10.1021/bi300865g · Cited by 18
“The aliphatic index for HDM2(25-47) and HDM4(25-47) is several times higher than similarly-sized ligands, including the NDR(62-87), p53(367-388), and RAGE(42-59) peptides (99).”
BackgroundInfluentialMouse models with modified p53 sequences to study cancer and ageing
Clarke, A. R., & Hollstein, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401188 · Cited by 19
Chandar, N., Swindle, J., Szajkovics, A., & Kolman, K. (2005) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2005.04.010 · Cited by 17
Oligonucleotide microarray data mining: search for age-dependent gene expression
Kirschner, M. W., Pujol, G. B., & Radu, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02563-9 · Cited by 17
Intimate relations: Evolutionary conflicts of pregnancy and childhood
Haig, D. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199207466.003.0006 · Cited by 19
Fiorini, A., Sultana, R., Barone, E., Cenini, G., Perluigi, M., Mancuso, C., Cai, J., Klein, J. B., St. Clair, D., & Butterfield, D. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049846 · Cited by 16
Modelling the p53/p66Shc Aging Pathway in the Shortest Living Vertebrate Nothobranchius Furzeri
Priami, C., De Michele, G., Cotelli, F., Cellerino, A., Giorgio, M., Pelicci, P. G., & Migliaccio, E. (2015) · Aging and Disease · doi:10.14336/ad.2014.0228 · Cited by 16
“The expression of dominant active p53 isoforms, that induce overall p53 stabilization and the consequent activation of p53 dependent senescence and apoptotic pathways, is associated with impairment of tissue renewal and premature aging [40,41].”
BackgroundSignaling pathways and targeted interventions for precancers
Yang, J., Wang, S., Li, X., Xu, H. E., Sun, T., Hu, T., Luo, J., & Zhou, H. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02342-4 · Cited by 20
“86 However, malignant cells are able to escape senescence through atypical mitotic reprogramming, as evidenced by keratinocytes employing asymmetric cell division via membrane budding, 87,88 bypassing growth arrest and promoting epithelial transformation.”
Relationships Between Regeneration, Wound Healing, and Cancer
Maggiore, G., & Zhu, H. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-123558 · Cited by 20
Dlx3 Ubiquitination by Nuclear Mdm2 Is Essential for Dentinogenesis in Mice
Zheng, H., Fu, J., Chen, Z., Yang, G., & Yuan, G. (2022) · Journal of Dental Research · doi:10.1177/00220345221077202 · Cited by 16
“p53 activation is also associated with aging, for p53 mutant mice with p53 activation exhibited an early onset of aging (Tyner et al. 2002; Lessel et al. 2017).”
Pharmacogenetics and Pharmagenomics, Trends in Normal and Pathological Aging Studies: Focus on p53
Lanni, C., Racchi, M., Uberti, D. L., Mazzini, G., Stanga, S., Sinforiani, E., Memo, M., & Govoni, S. M. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786264133 · Cited by 18
Is NHEJ a tumor suppressor or an aging suppressor?
Hasty, P. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5807 · Cited by 22
Yazinski, S. A., Westcott, P. M. K., Ong, K., Pinkas, J., Peters, R. M., & Weiss, R. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904965106 · Cited by 23
Smurf2 regulates hematopoietic stem cell self‐renewal and aging
Ramkumar, C., Kong, Y., Trabucco, S. E., Gerstein, R. M., & Zhang, H. (2014) · Aging Cell · doi:10.1111/acel.12195 · Cited by 17
“Moreover, mice with one wild-type allele and one mutant allele of p53 that lacks the N-terminal transactivation domain maintain cancer protection, but age prematurely including impairment of HSCs (Tyner et al. , 2002; Maier et al. , 2004; Dumble et al. , 2007).”
BackgroundELKAHLOUN, A. G., & Saavedra, J. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01800-9 · Cited by 17
Research Issues on Human Longevity
Robine, J. (2007) · Springer eBooks · doi:10.1007/978-1-4020-4848-7_1 · Cited by 19
Lin, S., Karoly, E. D., & Taatjes, D. J. (2013) · Aging Cell · doi:10.1111/acel.12108 · Cited by 18
“The role of p53 in mammalian aging is best exemplified by mouse studies with p53 truncation mutants (Tyner et al., 2002; Maier et al., 2004).”
BackgroundInfluentialRunning on empty: How p53 controls INS/IGF signaling and affects life span
Scrable, H. J., Medrano, S., & Ungewitter, E. K. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.05.017 · Cited by 19
“A similar mutation in the murine p53 gene (p53), however, causes accelerated aging and decreased life span in a mammalian species (Tyner et al., 2002).”
BackgroundInfluentialItzhaki, O., Kaptzan, T., Skutelsky, E., Sinai, J., Michowitz, M., Siegal, A., Schibi, G., Huszar, M., Ben-Dor, L., & Leibovici, J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.11.009 · Cited by 16
“Indeed, tumor suppression was recently found to be accompanied by accelerated aging in p53overexpressing mice [41] and antitumoral intervention has been suggested to eventually affect aging [42], possibly via apoptosis.”
BackgroundIs (Your Cellular Response to) Stress Killing You?
Sierra, F. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.6.557 · Cited by 17
Metadata
- Authors
- Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley, A., & Donehower, L. A.
- Affiliations
- Baylor College of Medicine (US)
- University of Massachusetts Chan Medical School (US)
- Leibniz Institute of Virology (LIV) (DE)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Nature
- Published
- 2002-01
- Volume
- 415
- Issue
- 6867
- Pages
- 45-53
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2171317581
- Cited by
- 1,459
- References
- 42
- Citations by year
- 2026: 20 · 2025: 19 · 2024: 17 · 2023: 41 · 2022: 30 · 2021: 45 · 2020: 36 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 52 · 2015: 52 · 2014: 60 · 2013: 64 · 2012: 69
- FWCI
- 27.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p53, aging, longevity, osteoporosis, organ atrophy, stress tolerance, transgenic mice, apoptosis, cellular senescence
- MeSH terms
- Adipose Tissue, Aging, Alleles, Animals, Body Weight, Bone and Bones, Cell Transformation, Neoplastic, Cells, Cultured, Exons, Female, Hair, Longevity, Male, Mice, Transgenic, Neoplasms, Organ Size, Osteoporosis, Phenotype, RNA, Messenger, Skin, Wound Healing, Genes, p53, Tumor Suppressor Protein p53, Sequence Deletion, Aging, Premature, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.